Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06044649 · ClinicalTrials.gov registry record · NA

Moderators and Mediators (M & M Trial) of Psychosocial Treatments of Chronic Pain

A NA study of Chronic Pain and Back Pain, sponsored by Rush University Medical Center.

Recruiting
Registry status
NA
Development phase
460
Enrollment target
2
Study locations

NCT06044649: Recruiting NA study of Chronic Pain and Back Pain, sponsored by Rush University Medical Center.

NCT06044649 is a NA study of Chronic Pain and Back Pain that is actively recruiting participants, run by Rush University Medical Center. The registered enrollment target is 460 participants, below the 771-participant average among 301 other Chronic Pain trials with a reported enrollment target (40% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06044649, a NA study of Chronic Pain and Back Pain, is actively recruiting participants, sponsored by Rush University Medical Center.

RECRUITING
Registry status
NA
Development phase
460 participants
Enrollment target
2
Study locations

Study Summary

Chronic musculoskeletal pain (CP) is a major public health concern. Psychosocial treatments have been shown to be efficacious when compared to largely inert control conditions, but they are characterized by modest effects on primary outcomes. One strategy to boost efficacy is to increase our understanding of treatment mediators. Studies of mediators that directly compare different treatments with each other are needed to determine which mediators are treatment-specific, which are shared across treatments, and which contribute the most to clinical outcomes. Another strategy is to identify the patient characteristics that moderate treatment responses. Research is needed that is guided by theoretical models and that tests moderators across multiple treatments. Identifying subgroups of patients more likely to respond to one or another treatment can advance precision medicine by informing a priori patient-treatment matches that can optimize treatment effects. To accomplish these goals, the authors will conduct a randomized clinical trial to compare the mediators and moderators of the clinical effects of Cognitive-Behavioral Therapy (CBT), Acceptance and Commitment Therapy (ACT), and Emotional Awareness and Expression Therapy (EAET) on adults with chronic spinal (axial) pain. Following baseline assessment of outcome variables as well as potential mediators and moderators, 460 participants will be randomized to CBT, ACT, EAET, or treatment-as-usual control (TAU). The three treatments will be conducted as individual therapy provided weekly for 8 weeks via telehealth. The researchers will conduct weekly assessments of both potential mediators and outcomes, as well as post-treatment and 6-month follow-up assessments. The goal of the study is to identify the most powerful treatment mechanisms - specific and shared -- and reveal for whom the mediator-outcome pathways are strongest.This project can increase the effects of our psychosocial chronic pain treatments by identifying t

Primary Outcome

4-item measure of pain severity over past week (range 0 to 10; higher scores = worse pain severity)

Interventions

  • BEHAVIORAL Emotional Awareness and Expression Therapy
  • OTHER Treatment as Usual
  • BEHAVIORAL Cognitive Behavioral Therapy
  • BEHAVIORAL Acceptance and Commitment Therapy

Study Locations (2)

Illinois

  • Rush University Medical Center - Chicago

Michigan

  • Wayne State University - Detroit

Trial Details

FieldValue
Enrollment Target 460 participants
Start Date 2023-11-15
Est. Completion 2027-03-30
Phase NA
Rush University Medical Center

320 total trials

What NCT06044649 shows while recruiting

NCT06044649 is an interventional study that assigns participants to a tested intervention. The registered 460 participants enrollment target is mid-sized for trials with a published cap, below the 771-participant average among 301 other Chronic Pain trials with a reported enrollment target (40% lower).

The record links to 3 conditions, with Chronic Pain appearing as the primary indexed condition, and to 4 interventions - of which Emotional Awareness and Expression Therapy is the first listed.

NCT06044649 reports a single indexed study location in Illinois, Michigan.

Frequently Asked Questions

What is clinical trial NCT06044649 about?

NCT06044649 is a clinical study titled "Moderators and Mediators (M & M Trial) of Psychosocial Treatments of Chronic Pain". Chronic musculoskeletal pain (CP) is a major public health concern. Psychosocial treatments have been shown to be efficacious when compared to largely inert control conditions, but they are characterized by modest effects on primary outcomes. One strategy to boost efficacy is to increase our underst...

What is the current status of trial NCT06044649?

This trial is currently recruiting. It is a NA study. The enrollment target is 460 participants. The study started on 2023-11-15. Estimated completion is 2027-03-30.

What conditions does trial NCT06044649 study?

This clinical trial studies the following conditions: Chronic Pain, Back Pain, Neck Pain.

What interventions are being tested in trial NCT06044649?

The interventions under investigation include: Emotional Awareness and Expression Therapy (BEHAVIORAL), Treatment as Usual (OTHER), Cognitive Behavioral Therapy (BEHAVIORAL), Acceptance and Commitment Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT06044649?

This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06044649 being conducted?

This trial has 2 study locations across Illinois, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06044649's enrollment target sits among peer trials

460 24th of 301 higher than 278 of 301 other Chronic Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02977780 · 460 participants · Phase 2

    INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)

  • NCT03427736 · 460 participants

    Anesthetics and Analgesics in Children

  • NCT03819933 · 460 participants · NA

    Optimizing Family Counseling for Anticipated Extremely Preterm Delivery

  • NCT04621279 · 460 participants

    Cool Prime Comparative Effectiveness Study for Mild HIE

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06044649, the US trial registry maintained by the National Library of Medicine. NCT06044649 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.